Atlanta Cancer Care - Cumming
Cumming, Georgia, United States
Cancer treatment center in Cumming, Georgia
Bldg 1505, 1505 Northside Blvd #4600, Cumming, GA 30041
About Atlanta Cancer Care - Cumming
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Gilead Sciences
1
Clinical Trials at Atlanta Cancer Care - Cumming
During the past decade, Atlanta Cancer Care - Cumming conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
2017-11-07
2020-12-08
Completed
529
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
2017-11-01
2021-08-31
Completed
95
Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
2018-06-18
2023-02-08
Active, not recruiting
202
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Atlanta Cancer Care - Cumming
According to Clinical.Site data, the most researched conditions in "Atlanta Cancer Care - Cumming" are
"Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Genes, BRCA 1" (1 trials) and "Locally Advanced or Metastatic Solid Tumors" (1 trials). Many other conditions were trialed in "Atlanta Cancer Care - Cumming" in a lesser frequency.
Clinical Trials Intervention Types at Atlanta Cancer Care - Cumming
Most popular intervention types in "Atlanta Cancer Care - Cumming" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Capecitabine" (1 trials), "Eribulin" (1 trials), "Gemcitabine" (1 trials) and "PF-06804103" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Atlanta Cancer Care - Cumming
The vast majority of trials in "Atlanta Cancer Care - Cumming" are
3 trials for "All" genders.
Clinical Trials Status at Atlanta Cancer Care - Cumming
Currently, there are NaN active trials in "Atlanta Cancer Care - Cumming".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Atlanta Cancer Care - Cumming,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Atlanta Cancer Care - Cumming, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".